Search

Search Constraints

You searched for: Author/Creator Anand, Inder S

Search Results

1. Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF). (21st August 2020)

2. Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction. (12th January 2023)

3. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I‐Preserve). (23rd May 2014)

4. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. (29th August 2020)

5. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. (November 2019)

7. Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. (15th August 2021)

8. Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial. Issue 1 (23rd June 2015)

9. Trend in prevalence of coronary artery disease and risk factors over two decades in rural Punjab. Issue 2 (14th September 2017)